Life

Health, science, climate, and society-focused reporting.

HHS Reverts Health IT Office Name to National Coordinator

The Trump administration has officially reverted the name of the federal health IT office to the Office of the National Coordinator, effective March 31, 2026.

Editorial Staff Mar 31

Life

Analysis of Executive Actions on U.S. Global Health by the Trump Administration

This overview details the executive orders and actions taken by the Trump Administration since January 21, 2025, impacting U.S. global health initiatives.

Editorial Staff Mar 31

Life

U.S. Life Expectancy Trends and International Comparisons

The latest data shows a slight increase in U.S. life expectancy, now at 79.0 years, but how does this compare to other wealthy nations?

Editorial Staff Mar 31

Life

FDA Regulations Challenge Custom Gene Editing Efforts for Baby KJ's Treatment

The pursuit of scalable gene editing solutions, as demonstrated in the case of Baby KJ, faces significant hurdles due to stringent FDA regulations.

Editorial Staff Mar 31

Life

Supreme Court Decision Impacts State Bans on Conversion Therapy

The Supreme Court's ruling against Colorado's ban on conversion therapy has significant implications for state-level mental health regulations and infrastructure.

Editorial Staff Mar 31

Life

OpenEvidence Partners with Major Health System to Enhance Record Sharing

OpenEvidence has formed a partnership with a significant health system aimed at improving the accessibility of health records, amidst increasing pressure on HHS regarding sharing policies.

Editorial Staff Mar 31

Life

Pharmaceutical Launch Delays in Europe Linked to U.S. Pricing Policies

Drugmakers are postponing the introduction of new medications in Europe, influenced by changes in U.S. pricing policies and market pressures.

Editorial Staff Mar 31

Life

Survey Highlights Mental Health Outcomes Related to Gender Euphoria

A recent survey has shed light on the mental health outcomes associated with gender euphoria, contributing to the ongoing discourse on gender identity and well-being.

Editorial Staff Mar 31

Life

Regulatory Scrutiny Intensifies for Psychedelic Biotechs Amid Acquisition Moves

Psychedelic biotech companies are facing increased regulatory scrutiny, coinciding with acquisition efforts from Biogen and Eli Lilly, while Gilead faces criticism from Doctors Without Borders.

Editorial Staff Mar 31

Life

Whoop Secures $575 Million Funding, Achieving $10 Billion Valuation

Whoop, known for its health and fitness tracking technology, has raised $575 million, leading to a valuation of $10 billion, with significant backing from the Mayo Clinic and Qatar's sovereign wealth fund.

Editorial Staff Mar 31

Life

Analysis of Public Sentiment on Prescription Drug Pricing

Recent KFF poll findings reveal significant public concerns regarding prescription drug costs, highlighting implications for healthcare infrastructure and policy.

Editorial Staff Mar 31

Life

Biogen's $5.6 Billion Acquisition of Apellis: Implications for Immunology Infrastructure

Biogen's acquisition of Apellis Pharmaceuticals for $5.6 billion marks a significant move to enhance its immunology portfolio, with potential impacts on market capacity and operational frameworks.

Editorial Staff Mar 31

Life

U.S. Venture Capital Firms Shift Focus to Upstream Biotech Investments in China

Amid intensifying competition, U.S. venture capital firms are adapting their strategies by investing directly in upstream scientific pipelines within China's biotech sector.

Editorial Staff Mar 31

Life

Strategic Recommendations for the Next CDC Director to Restore Trust

The CDC is at a critical juncture, requiring a strategic overhaul to regain public confidence, as emphasized by health experts.

Editorial Staff Mar 31

Life

Takeda Pharmaceuticals to Implement Workforce Reductions in Cambridge

Takeda Pharmaceuticals, the leading biopharma employer in Massachusetts, is set to lay off 250 employees in Cambridge starting July 2026, impacting local operational capacity.

Editorial Staff Mar 30

Life

Gilead's Refusal to Supply Lenacapavir Raises Concerns for HIV Prevention Efforts

Doctors Without Borders has criticized Gilead Sciences for declining to provide lenacapavir, a crucial HIV prevention drug, after lengthy negotiations.

Editorial Staff Mar 30

Life

Exploring the Intersection of Diet and Mental Health: Insights from Metabolic Psychiatry

Shebani Sethi, a Stanford psychiatrist, is pioneering research in metabolic psychiatry, focusing on how dietary choices may impact serious mental health disorders.

Editorial Staff Mar 30

Life

Implementation Insights on 2025 Reconciliation Law: Medicaid Work Requirements

An analysis of state and national data reveals the ongoing implementation of Medicaid work requirements under the 2025 Reconciliation Law.

Editorial Staff Mar 30

Life

AI-Driven Analysis of Brain Scans Enhances Early Alzheimer’s Detection

Researchers are leveraging AI technology to analyze brain scans, achieving a prediction accuracy of nearly 93 percent for Alzheimer’s disease.

Editorial Staff Mar 30

Life

Long-term Risks of Lead Exposure on Cardiovascular Health Identified

A recent study published in JAMA highlights the prolonged effects of lead exposure on cardiovascular health, emphasizing its impact on blood pressure and vessel integrity.

Editorial Staff Mar 30